Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1221, 2008-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bevacizumab/paclitaxel: Nasal septum perforation: case report
Reactions Weekly, Vol. 1, Iss. 1388, 2012-01 ,pp. :
Bevacizumab: Fusariosis (first report) and nasal septum perforation: case report
Reactions Weekly, Vol. 1, Iss. 1167, 2007-01 ,pp. :
Docetaxel: First report of nasal septal perforation: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1118, 2006-01 ,pp. :